Hexarelin-induced GH, cortisol and prolactin release: dose-response study
Hexarelin produced dose-dependent GH and prolactin responses and a cortisol increase at higher doses; low-dose hexarelin was synergistic with GHRH for GH release.
What this study tells us
This was a human pharmacology or physiology study. It can show what the compound does to measured biological signals, but it may not establish a meaningful clinical benefit.
Healthy adult men
n=Small study
Hexarelin produced dose-dependent GH and prolactin responses and a cortisol increase at higher doses; low-dose hexarelin was synergistic with GHRH for GH release.
Acute small study; no evidence for long-term performance, recovery or anti-ageing benefit.
Need help with terms such as randomized, placebo, endpoint or sample size? Open the glossary →
Key result
Hexarelin produced dose-dependent GH and prolactin responses and a cortisol increase at higher doses; low-dose hexarelin was synergistic with GHRH for GH release.